Goldman Sachs Group Inc. Has $87.96 Million Stock Holdings in IDEX Corporation $IEX

Goldman Sachs Group Inc. decreased its holdings in shares of IDEX Corporation (NYSE:IEXFree Report) by 27.9% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 494,336 shares of the industrial products company’s stock after selling 190,940 shares during the period. Goldman Sachs Group Inc.’s holdings in IDEX were worth $87,962,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of IEX. Primecap Management Co. CA raised its holdings in IDEX by 250.7% during the third quarter. Primecap Management Co. CA now owns 1,730,580 shares of the industrial products company’s stock worth $281,669,000 after buying an additional 1,237,129 shares during the last quarter. Norges Bank acquired a new position in IDEX during the fourth quarter worth $162,788,000. Dodge & Cox acquired a new position in IDEX during the third quarter worth $56,045,000. Two Sigma Investments LP raised its holdings in IDEX by 446.8% during the third quarter. Two Sigma Investments LP now owns 329,337 shares of the industrial products company’s stock worth $53,603,000 after buying an additional 269,109 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in IDEX by 16.1% during the third quarter. Invesco Ltd. now owns 1,809,788 shares of the industrial products company’s stock worth $294,561,000 after buying an additional 250,447 shares during the last quarter. Institutional investors and hedge funds own 97.96% of the company’s stock.

IDEX Stock Performance

Shares of IEX stock opened at $221.99 on Wednesday. The firm has a 50-day moving average of $206.77 and a 200-day moving average of $196.38. The company has a market cap of $16.43 billion, a P/E ratio of 32.84, a P/E/G ratio of 2.14 and a beta of 1.00. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.39 and a quick ratio of 2.40. IDEX Corporation has a one year low of $157.25 and a one year high of $223.85.

IDEX (NYSE:IEXGet Free Report) last announced its earnings results on Wednesday, April 29th. The industrial products company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.78 by $0.22. The company had revenue of $886.90 million during the quarter, compared to the consensus estimate of $845.58 million. IDEX had a net margin of 14.38% and a return on equity of 15.29%. The firm’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.75 earnings per share. IDEX has set its Q2 2026 guidance at 2.070-2.120 EPS and its FY 2026 guidance at 8.350-8.550 EPS. Equities research analysts forecast that IDEX Corporation will post 8.49 EPS for the current fiscal year.

IDEX Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 5th. Shareholders of record on Friday, May 22nd were paid a $0.73 dividend. The ex-dividend date was Friday, May 22nd. This is a positive change from IDEX’s previous quarterly dividend of $0.71. This represents a $2.92 dividend on an annualized basis and a yield of 1.3%. IDEX’s dividend payout ratio is presently 43.20%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Stifel Nicolaus set a $250.00 price objective on shares of IDEX in a report on Thursday, April 30th. BMO Capital Markets began coverage on shares of IDEX in a report on Friday, March 27th. They set a “market perform” rating and a $214.00 price objective on the stock. TD Cowen increased their target price on shares of IDEX from $250.00 to $260.00 and gave the company a “buy” rating in a report on Thursday, April 30th. Robert W. Baird set a $257.00 target price on shares of IDEX in a report on Thursday, April 30th. Finally, Royal Bank Of Canada increased their target price on shares of IDEX from $225.00 to $252.00 and gave the company an “outperform” rating in a report on Thursday, April 30th. Six research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $241.11.

Read Our Latest Report on IEX

Insiders Place Their Bets

In other IDEX news, CEO Eric D. Ashleman sold 15,385 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $215.22, for a total value of $3,311,159.70. Following the transaction, the chief executive officer directly owned 66,658 shares in the company, valued at $14,346,134.76. The trade was a 18.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.50% of the stock is currently owned by insiders.

About IDEX

(Free Report)

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.

Read More

Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEXFree Report).

Institutional Ownership by Quarter for IDEX (NYSE:IEX)

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.